Study: The Pill Reduces Cancer Risk
Posted on: Wednesday, 12 September 2007, 12:00 CDT
The birth control pill does not raise a woman's cancer risk and may reduce some cancer risk, but not if used for more than eight years, a Scottish study found.
First author Philip C. Hannaford and researchers from the University of Aberdeen analyzed data on 46,000 women over a 36-year period from the Royal College of General Practitioners Oral Contraception Study which began in 1968.
Approximately half of the women used oral contraceptives; half never used the pill. Every six months the woman's doctor provided the study with information on the her health and 75 percent of the women were flagged so that deaths and cancers were reported even if women left their doctor.
Overall there was no increased risk of cancer among pill users, but in the doctor observation data set for women who had taken the pill for some time there was a 3 percent reduced risk of developing any cancer. However, for the data set of the cancers notified via the central National Health Service registries, the reduction in cancer risk was 12 percent, the study published in the British Medical Journal Online First reported.
Women who used the pill for more than eight years had a statistically significant increased risk of developing any cancer -- in particular cervical and central nervous system cancer.
Source: United Press International
Related Articles
- Breast Cancer Will Risk Increases For Smokers and Overweight Women
- Detect second breast cancer, reduce risk
- Oncolytics Biotech Inc. Treats 200th Cancer Patient in Clinical Studies With REOLYSIN(R)
- Skin Flaps Deliver Cancer-Fighting Therapy, ASPS Study Reveals
- Women's Risk of HIV From Husbands
- AviaraDx, Inc. Announces Publication of Study With Baylor College of Medicine Demonstrating a Novel Two-Gene Ratio Is a Prognostic Indicator of Breast Cancer Recurrence Risk
- Thyroid Cancer Raises Risk of Second Cancer
- Young women risk chlamydia more than once: study
- Stress May Reduce Women's Risk of Breast Cancer
- CORRECTING AND REPLACING Study of Claims Data Finds REMICADE Dosing Remains Stable With Maintenance Therapy Over Two Year Period
User Comments (0)

RSS Feeds